MusclePharm Corp (OTCMKTS:MSLP) is a Denver-based sports nutrition company that develops, manufactures and markets dietary supplements designed for athletes and active consumers. Since its founding in 2008, the company has focused on research-driven formulations and manufacturing its products under Good Manufacturing Practice (GMP) guidelines. MusclePharm’s product portfolio spans protein powders, amino acid blends, pre-workout energizers, post-workout recovery aids and weight-management supplements.
The company’s flagship offerings include its Combat™ protein series, Assault™ pre-workout powder, and Re‐Con™ recovery blend, each formulated to support specific stages of the training cycle. In addition to core sports nutrition, MusclePharm provides targeted formulas for joint health, hydration and daily wellness. Research and development efforts center on leveraging clinically studied ingredients to enhance performance, endurance and muscle repair.
MusclePharm distributes its products through a diversified network of e-commerce channels, specialty retailers, big-box stores and gyms. Its global footprint extends across North America, Europe, Asia and Australia, with strategic partnerships in key markets to broaden brand visibility and market share. The company’s multi‐channel approach includes direct-to-consumer sales via its website as well as agreements with national and regional distributors.
Leadership is headed by founder and CEO Brad Pyatt, an athlete who launched the company to bring high-quality supplements to competitive sports participants. The executive team combines expertise in product development, manufacturing and international business, supported by a board that emphasizes governance and long-term growth. Over its history, MusclePharm has secured endorsements and collaborative projects with professional athletes and fitness influencers to reinforce its position in the sports nutrition industry.
AI Generated. May Contain Errors.
Free MSLP Stock Alerts